Analyst Ratings For Horizon Pharma (NASDAQ:HZNP)
Today, Morgan Stanley raised its price target on Horizon Pharma (NASDAQ:HZNP) to $16.00 per share.
Some recent analyst ratings include
- 3/1/2018-Piper Jaffray Companies Reiterated Rating of Buy.
- 3/1/2018-Cowen Reiterated Rating of Buy.
- 1/12/2018-Mizuho Upgrade from a “Neutral ” rating to a ” Buy” rating.
- 10/22/2017-Stifel Nicolaus Reiterated Rating of Buy.
Recent Insider Trading Activity For Horizon Pharma (NASDAQ:HZNP)
Horizon Pharma (NASDAQ:HZNP) has insider ownership of 3.20% and institutional ownership of 84.39%.
- On 5/10/2017 Michael G Grey, Director, bought 10,000 with an average share price of $9.48 per share and the total transaction amounting to $94,800.00.
- On 3/1/2017 Robert Carey, EVP, sold 31,808 with an average share price of $16.03 per share and the total transaction amounting to $509,882.24.
- On 8/2/2016 Jeffrey W. Sherman, EVP, sold 2,900 with an average share price of $20.00 per share and the total transaction amounting to $58,000.00.
- On 6/15/2016 Virinder Nohria, Director, sold 25,000 with an average share price of $17.69 per share and the total transaction amounting to $442,250.00.
- On 2/26/2016 Jeffrey W Sherman, EVP, sold 4,100 with an average share price of $20.00 per share and the total transaction amounting to $82,000.00.
- On 12/10/2015 Jeffrey W Sherman, EVP, sold 4,456 with an average share price of $20.00 per share and the total transaction amounting to $89,120.00.
- On 9/21/2015 Jeffrey W Sherman, EVP, sold 7,750 with an average share price of $31.78 per share and the total transaction amounting to $246,295.00.
Recent Trading Activity for Horizon Pharma (NASDAQ:HZNP)
Shares of Horizon Pharma closed the previous trading session at 15.30 up +0.52 3.52% with shares trading hands.